| Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in … C Arsov, R Rabenalt, D Blondin, M Quentin, A Hiester, E Godehardt, ... European urology 68 (4), 713-720, 2015 | 214 | 2015 |
| Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard L Schimmöller, M Quentin, C Arsov, RS Lanzman, A Hiester, R Rabenalt, ... European radiology 23, 3185-3190, 2013 | 138 | 2013 |
| Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with … M Quentin, D Blondin, C Arsov, L Schimmöller, A Hiester, E Godehardt, ... The Journal of urology 192 (5), 1374-1379, 2014 | 121 | 2014 |
| MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy L Schimmöller, M Quentin, C Arsov, A Hiester, C Buchbender, R Rabenalt, ... European radiology 24, 2582-2589, 2014 | 112 | 2014 |
| Long-term outcomes of salvage lymph node dissection for nodal recurrence of prostate cancer after radical prostatectomy: not as good as previously thought CA Bravi, N Fossati, G Gandaglia, N Suardi, E Mazzone, D Robesti, ... European urology 78 (5), 661-669, 2020 | 91 | 2020 |
| Feasibility of diffusional kurtosis tensor imaging in prostate MRI for the assessment of prostate cancer: preliminary results M Quentin, G Pentang, L Schimmöller, O Kott, A Müller-Lutz, D Blondin, ... Magnetic resonance imaging 32 (7), 880-885, 2014 | 84 | 2014 |
| The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy C Arsov, N Becker, R Rabenalt, A Hiester, M Quentin, F Dietzel, G Antoch, ... Journal of cancer research and clinical oncology 141, 2061-2068, 2015 | 65 | 2015 |
| Predictive power of the ESUR scoring system for prostate cancer diagnosis verified with targeted MR-guided in-bore biopsy L Schimmöller, M Quentin, C Arsov, A Hiester, P Kröpil, R Rabenalt, ... European journal of radiology 83 (12), 2103-2108, 2014 | 52 | 2014 |
| Risk stratification of equivocal lesions on multiparametric magnetic resonance imaging of the prostate T Ullrich, M Quentin, C Arsov, AK Schmaltz, A Tschischka, N Laqua, ... The Journal of urology 199 (3), 691-698, 2018 | 45 | 2018 |
| Phase 2 single-arm trial of primary retroperitoneal lymph node dissection in patients with seminomatous testicular germ cell tumors with clinical stage IIA/B (PRIMETEST) A Hiester, Y Che, A Lusch, O Kuß, G Niegisch, A Lorch, C Arsov, P Albers European Urology 84 (1), 25-31, 2023 | 38 | 2023 |
| Multiparametric magnetic resonance imaging/ultrasound fusion prostate biopsy—are 2 biopsy cores per magnetic resonance imaging lesion required? P Dimitroulis, R Rabenalt, A Nini, A Hiester, I Esposito, L Schimmöller, ... The Journal of urology 200 (5), 1030-1034, 2018 | 35 | 2018 |
| Underestimation of positron emission tomography/computerized tomography in assessing tumor burden in prostate cancer nodal recurrence: head-to-head comparison of 68Ga-PSMA and … N Fossati, S Scarcella, G Gandaglia, N Suardi, D Robesti, L Boeri, ... The Journal of Urology 204 (2), 296-302, 2020 | 31 | 2020 |
| The PRIMETEST trial: Interim analysis of a phase II trial for primary retroperitoneal lymph node dissection (RPLND) in stage II A/B seminoma patients without adjuvant treatment. P Albers, A Hiester, R Grosse Siemer, A Lusch Journal of Clinical Oncology 37 (7_suppl), 507-507, 2019 | 31 | 2019 |
| Comparison of patient comfort between MR-guided in-bore and MRI/ultrasound fusion-guided prostate biopsies within a prospective randomized trial C Arsov, R Rabenalt, M Quentin, A Hiester, D Blondin, P Albers, G Antoch, ... World journal of urology 34, 215-220, 2016 | 31 | 2016 |
| Preservation of ejaculatory function after postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) in patients with testicular cancer: template vs. bilateral resection A Hiester, A Nini, A Fingerhut, R große Siemer, C Winter, P Albers, ... Frontiers in Surgery 5, 80, 2019 | 29 | 2019 |
| Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study T Ullrich, C Arsov, M Quentin, F Mones, AC Westphalen, D Mally, ... European Radiology 30, 6042-6051, 2020 | 27 | 2020 |
| Value of dynamic contrast-enhanced (DCE) MR imaging in peripheral lesions in PI-RADS-4 patients T Ullrich, M Quentin, C Arsov, N Laqua, D Abrar, A Hiester, P Albers, ... RöFo-Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden …, 2020 | 26 | 2020 |
| PSMA PET/CT vs. CT alone in newly diagnosed biochemical recurrence of prostate cancer after radical prostatectomy: Comparison of detection rates and therapeutic implications J Morawitz, J Kirchner, J Lakes, NM Bruckmann, E Mamlins, A Hiester, ... European journal of radiology 136, 109556, 2021 | 25 | 2021 |
| Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required? L Schimmöller, M Quentin, D Blondin, F Dietzel, A Hiester, C Schleich, ... European radiology 26, 3858-3864, 2016 | 25 | 2016 |
| Assessing the best surgical template at salvage pelvic lymph node dissection for nodal recurrence of prostate cancer after radical prostatectomy: when can bilateral dissection … CA Bravi, N Fossati, G Gandaglia, N Suardi, E Mazzone, D Robesti, ... European urology 78 (6), 779-782, 2020 | 21 | 2020 |
